×

Biotech and Pharmaceuticals Medicine

  • Risk & compassionate use drug requests

    Compassionate use is a way for companies to provide experimental drugs outside of clinical trials for patients with no other options. CNBC's Meg Tirrell reports on the risks for patients and drug makers.

  • Ebola patient Writebol arrives in Atlanta

    The second American with Ebola has arrived in Atlanta, reports CNBC's Sue Herera.

  • Germ-zapping robot on 'Power Lunch'

    Xenex Disinfection Services hopes to fight the war against Ebola. Its CEO Morris Miller shares a demonstration of the company's disinfection robot Sara, which he claims can destroy a deadly virus in 5-10 minutes.

  • Battle for experimental drugs

    CNBC's Meg Tirrell explains how patients with serious diseases, who have exhausted hope from medicines on the market, turn to compassionate use campaigns.

  • Keith McCarty, Eaze founder & CEO, discuss his on-demand health care delivery technology that will automate patient verification and driver dispatch to hand deliver marijuana.

  • NY tests possible Ebola victim

    NBC's Jay Gray reports Ebola patient Nancy Writebol will arrive at Emory Hospital in Atlanta today.

  • Gaining access to experimental drugs

    Scott Gottlieb, M.D., American Enterprise Institute, and Jeff Allen, Friends of Cancer Research executive director, discuss the FDA's drug approval process and the need in some cases to allow access to experimental therapies.

  • Compassionate use: Nathalie's story

    Nathan Traller, father of young cancer patient Nathalie Traller, discusses the compassionate use of experimental drugs for patients.

  • Nathalie Traller back in the clinic.

    Terminally ill patients are increasingly seeking access experimental drugs outside clinical trials, but drug companies often decline these requests. A look at why.

  • Desperate measures for terminally ill

    CNBC's Meg Tirrell explains how compassionate use works and why it's the center of a lot of controversy.

  • Battling a rare cancer: Nathalie's story

    Nathalie Traller, a 15-year-old cancer patient, talks about the challenges of getting access to experimental treatments for a rare form of the disease.

  • Treating Nathalie Traller's cancer

    Nathalie Traller has a rare cancer, but at 15 years old, it's been difficult to get access to treatments.

  • NYC hospital testing patient for Ebola

    CNBC's Bertha Coombs reports a patient with a high fever and gastrointestinal symptoms is undergoing screenings to determine cause of symptoms at Mt. Sinai hospital.

  • Gloves and boots used by medical staff drying in the sun at a center for Ebola victims in Guinea.

    Ebola is now in 4 countries. NBC News' Sarah Daloff reports Emory Hospital in Atlanta, Georgia, is preparing for the arrival of the second Ebola patient Nancy Writebol.

  • A picture taken on June 28, 2014 shows a member of Doctors Without Borders (MSF) putting on protective gear at the isolation ward of the Donka Hospital in Conakry, where people infected with the Ebola virus are being treated.

    Dr. Frank Esper, University Hospitals Case Medical Center of Cleveland, Ohio, discusses the challenges of containing the outbreak of the highly infectious disease. We have the protocols in place for this kind of event and are up to the challenge, says Esper.

  • West African leaders and international health groups have stepped up plans to combat the world’s worst outbreak of the deadly Ebola virus.

  • A pharmacist searches for drugs in a pharmacy in Lagos, Nigeria, July, 2014.

    A dose of experimental serum arrived in Liberia to be tried on a U.S. charity worker—but there was only enough for one of the two infected workers, NBC.

  • The push back on Sovaldi

    Insurance companies are hurting from the high cost of hepatitis C drug Sovaldi. Arthur Caplan, NYU Langone Medical Center, and CNBC's Bertha Coombs, share their opinions.

  • CRE, one of the worst of the superbugs, is spreading in some hospitals, and there's worry that cases are under-reported.

  • A Liberian man is being tested for the deadly Ebola virus in Nigeria's commercial capital of Lagos, a megacity of 21 million people.